Abcam and MEDx extend precision medicine strategic partnership
Building on existing three-year collaboration Focusing on co-development of companion and in vitro diagnostic kits…
Building on existing three-year collaboration Focusing on co-development of companion and in vitro diagnostic kits…
The Number One Email Marketing App for Salesforce Improves Data Accessibility, Transactional Email and Insights…
TOKYO, Apr 12, 2021 – (JCN Newswire) – Eisai Co., Ltd. announced that its animation…
TOKYO, Apr 12, 2021 – (JCN Newswire) – Fujitsu today announced an agreement to collaborate…
Toyota City, Japan, Apr 12, 2021 – (JCN Newswire) – Lexus plans to display the…
HONG KONG, Apr 12, 2021 – (ACN Newswire) – As the fashion world continues to…
BEIJING, Apr 12, 2021 – (ACN Newswire) – Since the reform and opening-up, more than…
Comprehensive test and notification program ensures safety and provides peace of mind for IMG clients,…
This news release is not for distribution or dissemination in the United States of America…
MIAMI, FL / ACCESSWIRE / April 11, 2021 / The combat sports world is about…
– CFT7455 Demonstrated High Cereblon Binding Affinity and Rapid, Deep IKZF1/3 Degradation Enabling Activity across…
PC14586 selectively stabilizes the p53 Y220C mutant and restores p53 activity Robust in vivo tumor…
ZN-c3 demonstrated single agent activity, generating Exceptional Responses in a range of heavily pre-treated solid…
TH1902 anti-tumor post-treatment effect persists longer than with docetaxel alone MONTREAL, April 10, 2021 (GLOBE…
CAMBRIDGE, Mass., April 10, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical…
7 objective responses observed to date in multiple tumor types New responses reported in patients…
CAMBRIDGE, Mass., April 10, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
— Late-breaking presentation highlights preclinical data for AO-176 in T-ALL — BRISBANE, Calif., April 10,…
Preliminary data demonstrate a robust increase in HPV16+-specific T cells, including up to 8% of…
VIP236 shows enhanced tumor targeting with robust antitumor activity across multiple xenograft models First-in-human studies…